Protagenic Therapeutics, Inc. (PTIX)
Protagenic Therapeutics, Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in New York, NY, US. The stock last traded at $0.77, down 10.00% on the session, giving a market capitalisation of $1.4M. On trailing twelve-month figures it carries a trailing P/E of 0.26, a net margin of 0.0%. Its beta of 1.07 implies it has historically moved more than the broad market.
Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. Protagenic Therapeutics, Inc. was founded in 2004 and is based in Santa Barbara, California.
Protagenic Therapeutics, Inc. is most often compared with the following Healthcare names: